Hepatitis B and your cancer risk

This article provides a comprehensive overview of hepatitis B (HBV) and its relationship to liver cancer and other potential health risks. Hepatitis B is a viral infection transmitted through infected blood and bodily fluids, which can lead to liver inflammation, fibrosis, cirrhosis, and ultimately liver cancer. The article emphasizes that HBV can be asymptomatic, making screening critical for early detection and prevention. All adults, particularly those with risk factors such as prior exposure, multiple sexual partners, or immunocompromised conditions, are advised to undergo blood testing for hepatitis B. Cancer patients are highlighted as a high-risk group due to potential complications during treatments that weaken the immune system. The article outlines prevention strategies, including vaccination, and discusses management and treatment options, such as oral antiviral medications, monitoring, and lifestyle adjustments to reduce the risk of liver damage and liver cancer. Practical guidance is also provided for safe interactions with family and partners, and for coordinating care during cancer treatment to prevent HBV reactivation.